Samsara BioCapital, L.P. 13D and 13G filings for Rani Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-28 5:47 pm Purchase | 2026-05-26 | 13D | RANI THERAPEUTICS HLDGS INC CO RANI | Samsara BioCapital, L.P. | 11,322,961 9.900% | 1,440,484 (+14.58%) | Filing |
| 2025-10-30 7:50 pm Purchase | 2025-10-23 | 13D | RANI THERAPEUTICS HLDGS INC CO RANI | Samsara BioCapital, L.P. | 9,882,477 9.900% | 9,882,477 (New Position) | Filing |